Cargando…
The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species
Treatment and control of schistosomiasis depends on a single drug, praziquantel, but this is not ideal for several reasons including lack of potency against the juvenile stage of the parasite, dose size, and risk of resistance. We have optimised the properties of a series of compounds we discovered...
Autores principales: | Gardner, J. Mark F., Mansour, Nuha R., Bell, Andrew S., Helmby, Helena, Bickle, Quentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321398/ https://www.ncbi.nlm.nih.gov/pubmed/34280206 http://dx.doi.org/10.1371/journal.pntd.0009490 |
Ejemplares similares
-
High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni
por: Mansour, Nuha R., et al.
Publicado: (2016) -
Comparison of Microscopy and Alamar Blue Reduction in a Larval Based Assay for Schistosome Drug Screening
por: Mansour, Nuha R., et al.
Publicado: (2010) -
Anthelmintic Activity In Vivo of Epiisopiloturine against Juvenile and Adult Worms of Schistosoma mansoni
por: Guimarães, Maria A., et al.
Publicado: (2015) -
Human helminth therapy to treat inflammatory disorders- where do we stand?
por: Helmby, Helena
Publicado: (2015) -
Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE)
por: Wu, Chenyun, et al.
Publicado: (2020)